Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000423131 | SCV000535204 | uncertain significance | not provided | 2024-04-16 | criteria provided, single submitter | clinical testing | Reported in an individual with ARVC who also harbored a variant in the DSP gene (PMID: 38204539); In silico analysis indicates that this missense variant does not alter protein structure/function; Also known as p.(M765R); This variant is associated with the following publications: (PMID: 38204539) |
| Labcorp Genetics |
RCV000423131 | SCV002199260 | uncertain significance | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 765 of the ALPK3 protein (p.Met765Arg). This variant is present in population databases (rs150028343, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with ALPK3-related conditions. ClinVar contains an entry for this variant (Variation ID: 392012). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ALPK3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Ambry Genetics | RCV002451048 | SCV002738112 | likely benign | Cardiovascular phenotype | 2024-04-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV005404569 | SCV006070214 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing | BP1, BP4 |
| Clinical Genetics, |
RCV000423131 | SCV001925705 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
| Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000423131 | SCV001976053 | uncertain significance | not provided | no assertion criteria provided | clinical testing |